2 recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow TQH3906 Capsule: new trials by email Literature Review of TQH3906 Capsule trials Research Report on TQH3906 Capsule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis TQH3906 Capsule, TQH3906 Placebo Capsule, Tofacitinib Citrate Tablet 5 mg - Psoriatic Arthritis | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 156 | 2026-07-16 | 2026-09-02 |
| A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus TQH3906 capsule, TQH3906 placebo - Systemic Lupus Erythematosus | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 198 | 2026-06-22 | 2026-07-08 |
| A Clinical Trial of TQH3906 Capsules in Healthy Volunteers TQH3906 capsule, TQH3906 placebo - Psoriasis | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 96 | 2024-02-02 | 2025-07-16 |
Arthritis, Psoriatic (1) · Lupus Erythematosus, Systemic (1) · Psoriasis (1)
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
China (3)